NIAID Banner Logo Image

HIV Citation List: April 25 - May 8, 2014

PubMed Citations

1. 1,4-Bis(5-(Naphthalen-1-yl)thiophen-2-yl)naphthalene, a Small Molecule, Functions as a Novel anti-HIV-1 Inhibitor Targeting the Interaction between Integrase and Cellular Lens Epithelium-derived Growth Factor. Gu, W.G., D.T. Ip, S.J. Liu, J.H. Chan, Y. Wang, X. Zhang, Y.T. Zheng, and D.C. Wan. Chemico-biological Interactions, 2014. 213: p. 21-27. PMID[24480521].

[PubMed]. HIV_0425-050814.


2. Anti-HIV Activities of Novel Synthetic Peptide Conjugated Chitosan Oligomers. Karagozlu, M.Z., F. Karadeniz, and S.K. Kim. International Journal of Biological Macromolecules, 2014. 66: p. 260-266. PMID[24556119].

[PubMed]. HIV_0425-050814.


3. Cepharanthine Inhibited HIV-1 Cell-cell Transmission and Cell-free Infection via Modification of Cell Membrane Fluidity. Matsuda, K., S. Hattori, Y. Komizu, R. Kariya, R. Ueoka, and S. Okada. Bioorganic & Medicinal Chemistry Letters, 2014. 24(9): p. 2115-2117. PMID[24704028].

[PubMed]. HIV_0425-050814.


4. The Fungal Metabolite Galiellalactone Interferes with the Nuclear Import of NF-kappaB and Inhibits HIV-1 Replication. Perez, M., R. Soler-Torronteras, J.A. Collado, C.G. Limones, R. Hellsten, M. Johansson, O. Sterner, A. Bjartell, M.A. Calzado, and E. Munoz. Chemico-biological Interactions, 2014. 214: p. 69-76. PMID[24631022].

[PubMed]. HIV_0425-050814.


5. PMPA and PMEA Prodrugs for the Treatment of HIV Infections and Human Papillomavirus (HPV) Associated Neoplasia and Cancer. Pertusati, F., K. Hinsinger, A.S. Flynn, N. Powell, A. Tristram, J. Balzarini, and C. McGuigan. European Journal of Medicinal Chemistry, 2014. 78: p. 259-268. PMID[24686012].

[PubMed]. HIV_0425-050814.


6. Diketoacid Chelating Ligands as Dual Inhibitors of HIV-1 Integration Process. Rogolino, D., M. Carcelli, C. Compari, L. De Luca, S. Ferro, E. Fisicaro, G. Rispoli, N. Neamati, Z. Debyser, F. Christ, and A. Chimirri. European Journal of Medicinal Chemistry, 2014. 78: p. 425-430. PMID[24704615].

[PubMed]. HIV_0425-050814.

ISI Web of Knowledge Citations

7. Synthesis of Anionic Carbosilane Dendrimers via "Click Chemistry" and Their Antiviral Properties against HIV. Arnaiz, E., E. Vacas-Cordoba, M. Galan, M. Pion, R. Gomez, M.A.A. Munoz-Fernandez, and F.J. de la Mata. Journal of Polymer Science Part A-Polymer Chemistry, 2014. 52(8): p. 1099-1112. ISI[000332043200006].

[WOS]. HIV_0425-050814.


8. Study of Marine Natural Products Including Resorcyclic acid Lactones from Humicola fuscoatra That Reactivate Latent HIV-1 Expression in an in Vitro Model of Central Memory CD4+T Cells. Mejia, E.J., S.T. Loveridge, G. Stepan, A. Tsai, G.S. Jones, T. Barnes, K.N. White, M. Draskovic, K. Tenney, M. Tsiang, R. Geleziunas, T. Cihlar, N. Pagratis, Y. Tian, H. Yu, and P. Crews. Journal of Natural Products, 2014. 77(3): p. 618-624. ISI[000333662700027].

[WOS]. HIV_0425-050814.


9. Bioactive Compounds from Vitex leptobotrys. Pan, W.H., K.L. Liu, Y.F. Guan, G.T. Tan, N.V. Hung, N.M. Cuong, D.D. Soejarto, J.M. Pezzuto, H.H.S. Fong, and H.J. Zhang. Journal of Natural Products, 2014. 77(3): p. 663-667. ISI[000333662700033].

[WOS]. HIV_0425-050814.


10. Aminodiols via Stereocontrolled Oxidation of Methyleneaziridines. Rigoli, J.W., I.A. Guzei, and J.M. Schomaker. Organic Letters, 2014. 16(6): p. 1696-1699. ISI[000333477400041].

[WOS]. HIV_0425-050814.


11. Monovalent Mannose-based DC-SIGN Antagonists: Targeting the Hydrophobic Groove of the Receptor. Tomasic, T., D. Hajsek, U. Svajger, J. Luzar, N. Obermajer, I. Petit-Haertlein, F. Fieschi, and M. Anderluh. European Journal of Medicinal Chemistry, 2014. 75: p. 308-326. ISI[000333775600032].

[WOS]. HIV_0425-050814.


12. Synthesis and Biological Evaluation of New Conformationally Restricted S-DABO Hybrids as Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase. Wu, H.Q., C. Pannecouque, Z.H. Yan, W.X. Chen, Q.Q. He, F.E. Chen, J. Balzarini, D. Daelemans, and E. De Clercq. MedChemComm, 2014. 5(4): p. 468-473. ISI[000333580000009].

[WOS]. HIV_0425-050814.


13. Synthesis and Biological Evaluation of Novel Quinoxalinone-based HIV-1 Reverse Transcriptase Inhibitors. Zhou, J., M.Y. Ba, B. Wang, H.B. Zhou, J.B. Bie, D.C. Fu, Y.L. Cao, B.L. Xu, and Y. Guo. MedChemComm, 2014. 5(4): p. 441-444. ISI[000333580000004].

[WOS]. HIV_0425-050814.

Patent Citations

14. Preparation of Pyrimidinyl Non-Nucleoside Reverse Transcriptase Inhibitors for Treatment of HIV Infection and AIDS. Arrington, K.L., C. Burgey, R. Gilfillan, Y. Han, M. Patel, C.S. Li, Y. Li, Y. Luo, and Z. Lei. Patent. 2014. 2013-14047515 20140100231: 132pp.

[Patent]. HIV_0425-050814.


15. Inhibitors of Viral Replication, Their Process of Preparation and Their Therapeutical Uses.Benarous, R., F. Chevreuil, B. Ledoussal, S. Chasset, and F. Le Strat. Patent. 2014. 2013-EP71321 2014057103: 229pp.

[Patent]. HIV_0425-050814.


16. Preparation of Substituted Thienylacetic acids as Inhibitors of Viral Replication. Benarous, R., F. Chevreuil, B. Ledoussal, S. Chasset, and F. Le Strat. Patent. 2014. 2013-EP70862 2014053666: 243pp.

[Patent]. HIV_0425-050814.


17. Preparation of Substituted Pyrazolylacetic acids as Inhibitors of Viral Replication.Benarous, R., F. Chevreuil, B. Ledoussal, S. Chasset, and F. Le Strat. Patent. 2014. 2013-EP70861 2014053665: 168pp.

[Patent]. HIV_0425-050814.



If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021